Exploring thrombus composition in cerebral venous thrombosis: the first case report with initial insights and implications for treatment advancements

Ghil Schwarz,Angelo Cascio Rizzo,Martina Di Como,Guglielmo Pero,Amedeo Cervo,Antonio Macera,Maria Costanza Aquilano,Cristina Motto,Marco Bacigaluppi,Alessandra Protti,Emanuela Bonoldi,Mariangela Piano,Elio Clemente Agostoni
DOI: https://doi.org/10.1007/s10072-024-07320-2
2024-01-16
Neurological Sciences
Abstract:Endovascular thrombectomy (EVT) is a treatment option in patients with a cerebral venous thrombosis (CVT) who deteriorate despite anticoagulant treatment. Assessment of thrombus composition in CVT may provide insights into the pathophysiology of the disease and suggest new therapeutic strategies.
neurosciences,clinical neurology
What problem does this paper attempt to address?
The paper primarily explores the thrombus components obtained through Endovascular Thrombectomy (EVT) in patients with Cerebral Venous Thrombosis (CVT) and conducts a detailed histological analysis of these components. The research background highlights that although anticoagulation therapy is the standard treatment for CVT, in some cases, patients' conditions may still deteriorate despite adequate anticoagulation therapy. In such instances, EVT can be considered a potential treatment option. The case report in the paper describes a 47-year-old female patient whose condition worsened after receiving anticoagulation therapy, leading to the performance of EVT. During the procedure, the thrombus was removed and subjected to histological evaluation. The evaluation results showed that the thrombus was primarily composed of red blood cells (accounting for 83.9% of the entire thrombus surface) and included platelet/fibrin layers (i.e., Zahn lines, with fibrin accounting for 13.9% and platelets for 38.5%). Additionally, the thrombus contained a significant number of neutrophils (30%), as well as small amounts of T cells, B cells, and monocytes/macrophages. No hemosiderin or endothelial cells were detected. The main conclusion of the study is that this is the first case report to conduct a histological evaluation of CVT thrombi obtained through EVT. A deeper understanding of the thrombus components can provide new insights into the pathophysiological mechanisms of CVT and guide future therapeutic advancements. Furthermore, the study emphasizes the need for larger-scale research to validate these preliminary findings and explore the relationship between thrombus components and CVT treatment outcomes.